---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-092879"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:23:22.565084+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NeuroOne expands Zimmer Biomet distribution deal for OneRF Ablation System; $3M upfront

## Summary
- Zimmer Biomet gets exclusive US and certain OUS distribution rights for OneRF Ablation System.
- NeuroOne receives $3M upfront within 10 business days plus up to $1M milestone payment.
- OneRF is only FDA-cleared RF ablation system for both diagnostic and therapeutic brain use.
- Agreement effective Oct 25, 2024, term to Sep 30, 2034 unless earlier terminated.
- NeuroOne expects meaningful revenue and improved profitability from the agreement.

## SEC filing metadata
- accession: 0001213900-24-092879
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390024092879/0001213900-24-092879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390024092879/ea0219340-8k_neuro.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-092879
- JSON: https://secwatch.observer/filing/0001213900-24-092879.json
- Plain text: https://secwatch.observer/filing/0001213900-24-092879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.